I certainly agree with you Hesk when you ask what is going on. For the history of the company it seems we are told we are on the edge, on the verge, at the forefront etc, yet here we are. I have never found a way yet to confirm truly if anyone is interested in anything we are doing. Even communicating with the company the same info comes back, seeming to indicate there is much interest but we are not quite there. Ultimately the only ones who know are directors and they bought more than most of us.
At the moment it seems to be one giant quandary as on the one hand a couple of board members own a huge number of shares so the bosses have no reason to sit back and burn cash. On the other hand we are told what we are doing is ground breaking yet obviously no deals and realistically nothing said that indicates we have interested parties in our offices looking for a reason to sign. i guess one component could be that they did clearly state they were no longer targetting small collaboration type deals like previous ones. In the past i think the only reason we got the deals we did was because they were ridiculously cheap for what they were. Maybe we could have 2 or 3 right now if that was what we wanted but maybe that is why Rohan is busy, trying to lock in a significant deal rather than another free access to our tech type collaboration where we tie up our now quite expensive labs and scans for months or years on someone elses target for 500k or 1 mil. Even genentech shows this o guess, with initial payment and then extension not amounting to much more than 3 million for around 5 years of collaboration?
PYC Price at posting:
3.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)